A Single-Agent Dual-Specificity Targeting of FOLR1 and DR5 as an Effective Strategy for Ovarian Cancer.

Journal: Cancer Cell

Published: 2018-08-13

DOI: 10.1016/j.ccell.2018.07.005

Affiliations: 8

Authors: 16

Go to article
Institutions FC
Department of Biochemistry and Molecular Genetics (BMG), UVA, United States of America (USA) 0.27
School of Medicine, UVA, United States of America (USA) 0.23
University of Virginia Cancer Center, United States of America (USA) 0.22
Department of Obstetrics and Gynecology, UVA, United States of America (USA) 0.09
Department of Microbiology, Immunology, and Cancer Biology (MIC), UVA, United States of America (USA) 0.06
Center for Cell Clearance (CCC), UVA, United States of America (USA) 0.06
Department of Pathology, UVA, United States of America (USA) 0.06

Return